Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo Pasquini

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TransplantationSteven Z Pavletic, Shaji Kumar, Mohamad Mohty, et al.
JAMA Network Open|July 6, 2019
Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US HospitalsBinod Dhakal, Smith Giri, Adam Levin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2019
Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell TransplantationSameem Abedin, Edward McKenna, Saurabh Chhabra, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 11, 2016
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on SurvivalBinod Dhakal, Anita D'Souza, Michael Martens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2014
Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosisBinod Dhakal, Christopher Strouse, Anita D'Souza, et al.
Transplantation and Cellular Therapy|September 20, 2024
Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell TransplantationOthman S Akhtar, Shanze Arshad, Qinghua Lian, et al.
Bone Marrow Transplantation|April 22, 2018
Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effectiveTalha Badar, Parameswaran Hari, Saurabh Chhabra, et al.
British Journal of Haematology|October 13, 2024
Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myelomaStephanie Yohay, Temitope Oloyede, Soyoung Kim, et al.
Hematology, Transfusion and Cell Therapy|November 19, 2021
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patientsAngelo Maiolino, Luciano J Costa, Marcelo Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2018
Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell TransplantationNarendranath Epperla, Mehdi Hamadani, Kwang W Ahn, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TransplantationSteven Z Pavletic, Shaji Kumar, Mohamad Mohty, et al.
JAMA Network Open|July 6, 2019
Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US HospitalsBinod Dhakal, Smith Giri, Adam Levin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2019
Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell TransplantationSameem Abedin, Edward McKenna, Saurabh Chhabra, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 11, 2016
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on SurvivalBinod Dhakal, Anita D'Souza, Michael Martens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2014
Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosisBinod Dhakal, Christopher Strouse, Anita D'Souza, et al.
Transplantation and Cellular Therapy|September 20, 2024
Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell TransplantationOthman S Akhtar, Shanze Arshad, Qinghua Lian, et al.
Bone Marrow Transplantation|April 22, 2018
Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effectiveTalha Badar, Parameswaran Hari, Saurabh Chhabra, et al.
British Journal of Haematology|October 13, 2024
Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myelomaStephanie Yohay, Temitope Oloyede, Soyoung Kim, et al.
Hematology, Transfusion and Cell Therapy|November 19, 2021
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patientsAngelo Maiolino, Luciano J Costa, Marcelo Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2018
Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell TransplantationNarendranath Epperla, Mehdi Hamadani, Kwang W Ahn, et al.
Pageof 9